PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.77%
Negative revenue growth while ADI stands at 1.52%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.16%
Negative gross profit growth while ADI is at 2.15%. Joel Greenblatt would examine cost competitiveness or demand decline.
-21.48%
Negative EBIT growth while ADI is at 2.87%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-21.73%
Negative operating income growth while ADI is at 2.87%. Joel Greenblatt would press for urgent turnaround measures.
-21.08%
Negative net income growth while ADI stands at 4.46%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-19.88%
Negative EPS growth while ADI is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-19.62%
Negative diluted EPS growth while ADI is at 0.93%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.65%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.92%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
24.31%
Dividend growth above 1.5x ADI's 1.00%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
1.85%
OCF growth under 50% of ADI's 15.10%. Michael Burry might suspect questionable revenue recognition or rising costs.
4.95%
FCF growth under 50% of ADI's 10.45%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
100.57%
10Y revenue/share CAGR 1.25-1.5x ADI's 90.85%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
39.89%
5Y revenue/share CAGR under 50% of ADI's 99.41%. Michael Burry would suspect a significant competitive gap or product weakness.
23.68%
3Y revenue/share CAGR at 50-75% of ADI's 37.67%. Martin Whitman would question if the firm lags behind competitor innovations.
157.89%
10Y OCF/share CAGR at 50-75% of ADI's 296.63%. Martin Whitman might fear a structural deficiency in operational efficiency.
103.87%
5Y OCF/share CAGR is similar to ADI's 114.46%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
59.17%
3Y OCF/share CAGR under 50% of ADI's 204.56%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
1456.48%
Net income/share CAGR above 1.5x ADI's 137.67% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
176.30%
5Y net income/share CAGR above 1.5x ADI's 81.94%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
57.27%
Below 50% of ADI's 279.42%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
29.63%
Below 50% of ADI's 258.57%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-5.16%
Negative 5Y equity/share growth while ADI is at 96.37%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-4.04%
Negative 3Y equity/share growth while ADI is at 82.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
601.64%
10Y dividend/share CAGR above 1.5x ADI's 143.86%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
157.27%
5Y dividend/share CAGR above 1.5x ADI's 43.44%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
102.33%
3Y dividend/share CAGR above 1.5x ADI's 20.57%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-23.85%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
4.77%
Inventory growth well above ADI's 4.10%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-7.73%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-13.04%
We have a declining book value while ADI shows 1.94%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.02%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.56%
R&D growth drastically higher vs. ADI's 1.39%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
4.55%
SG&A growth well above ADI's 2.28%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.